226 related articles for article (PubMed ID: 24286115)
1. A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injection.
Reutens AT; Balkau B; Cohen N
Diabetes Technol Ther; 2014 Apr; 16(4):235-40. PubMed ID: 24286115
[TBL] [Abstract][Full Text] [Related]
2. A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study.
Ma Z; Parkner T; Frystyk J; Laursen T; Lauritzen T; Christiansen JS
Diabetes Technol Ther; 2012 Jul; 14(7):589-95. PubMed ID: 22519735
[TBL] [Abstract][Full Text] [Related]
3. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
[TBL] [Abstract][Full Text] [Related]
4. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
5. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
6. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
7. Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.
Forst T; Hohberg C; Schöndorf T; Borchert M; Forst S; Roth W; Dehos B; Pfützner A
Diabetes Technol Ther; 2009 Feb; 11(2):87-92. PubMed ID: 19848574
[TBL] [Abstract][Full Text] [Related]
8. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
Lindholm A; McEwen J; Riis AP
Diabetes Care; 1999 May; 22(5):801-5. PubMed ID: 10332685
[TBL] [Abstract][Full Text] [Related]
9. Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes.
Kochba E; Levin Y; Raz I; Cahn A
Diabetes Technol Ther; 2016 Sep; 18(9):525-31. PubMed ID: 27500713
[TBL] [Abstract][Full Text] [Related]
10. Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.
Hermansen K; Vaaler S; Madsbad S; Dalgaard M; Zander M; Begtrup K; Soendergaard K
Metabolism; 2002 Jul; 51(7):896-900. PubMed ID: 12077738
[TBL] [Abstract][Full Text] [Related]
11. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
12. Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.
Engwerda EE; Tack CJ; de Galan BE
Diabetes Care; 2013 Nov; 36(11):3436-41. PubMed ID: 24089542
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus.
Heise T; Hövelmann U; Zijlstra E; Stender-Petersen K; Jacobsen JB; Haahr H
Drugs Aging; 2017 Jan; 34(1):29-38. PubMed ID: 27873152
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial.
Ruan Y; Elleri D; Allen JM; Tauschmann M; Wilinska ME; Dunger DB; Hovorka R
Diabetologia; 2015 Apr; 58(4):687-90. PubMed ID: 25537835
[TBL] [Abstract][Full Text] [Related]
15. Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
Zijlstra E; Coester HV; Heise T; Plum-Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T
Diabetes Obes Metab; 2018 May; 20(5):1140-1147. PubMed ID: 29369493
[TBL] [Abstract][Full Text] [Related]
16. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
[TBL] [Abstract][Full Text] [Related]
17. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
Pettis RJ; Hirsch L; Kapitza C; Nosek L; Hövelmann U; Kurth HJ; Sutter DE; Harvey NG; Heinemann L
Diabetes Technol Ther; 2011 Apr; 13(4):443-50. PubMed ID: 21355716
[TBL] [Abstract][Full Text] [Related]
18. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes.
de Wit HM; Engwerda EE; Tack CJ; de Galan BE
Diabetes Obes Metab; 2015 Nov; 17(11):1093-9. PubMed ID: 26259978
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the pharmacodynamic profiles of jet-injected regular human insulin versus conventionally administered insulin aspart in healthy volunteers.
Engwerda EEC; Tack CJ; de Galan BE
Diabetes Res Clin Pract; 2016 Nov; 121():86-90. PubMed ID: 27662042
[TBL] [Abstract][Full Text] [Related]
20. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
